Circulating tumor DNA mutational landscape and dynamics after progression on a CDK4/6 inhibitor in the PACE phase II trial for metastatic HR-positive/HER2-negative breast cancer

Publication Date

2025

Content Type

Article

PubMed ID:

40714513

Additional Authors:

Additional authors and institutional affiliations

This document is currently not available here.

Share

COinS